REFERENCES
- Menzies D, Ellis H. Intestinal obstruction from adhesions: how big is the problem? Ann R Coll Surg Eng. 1990;72:60–63.
- Menzies D. Peritoneal adhesions: incidence, cause and prevention. Surg Ann. 1992;24:27–45.
- Canis M, Botchorishvili R, Wattiez A, Prevention of peritoneal adherences. Eur J Obstet & Gynecol & Reprod Biol. 2001;30:305–324.
- Roman H, Canis M, Kamble M, Efficacy of three adhesion-preventing agents in reducing severe peritoneal trauma induced by bipolar coagulation in a laparoscopic rat model. Fertil Steril. 2005;83:1113–1118.
- Cheong YC, Li TC, Laird SM, Peritoneal healing and adhesion formation/reformation. Hum Reprod Update 2001;7:556–566.
- Burns JW, Skinner K, Colt MJ, A hyaluronate based gel for the prevention of post surgical adhesions: evaluation in two animal species. Fertil Steril. 1996;66:814–821.
- Holtz G. Prevention of postoperative adhesions. J Reprod Med. 1980;24:141–146.
- Gomel V, Urman B, Gurgan T. Pathophysiology of adhesion formation and strategies for prevention. J Reprod Med. 1996;41:35–41.
- Parks WC. Matrix metalloproteinases in repair. Wound Rep Regen. 1999;7:423–432.
- Parsons SL, Watson SA, Brown PD, Matrix metalloproteinases. Br J Surg. 1997;84:160–166.
- Lee MH, Murphy G. Matrix metalloproteinases at a glance. J Cell Sci. 2004;117:4015–4016.
- Vaalamo M, Leivo T, Saarialho-Kere U, Differential expression of tissue inhibitors of metalloproteinases (TIMP-1,-2,-3,-4) in normal and aberrant wound healing. Hum Path. 1999;30:795–802.
- Marshall BC, Santana A, Xu Q, Peterson MJ, Metalloproteinases and tissue inhibitor of metalloproteinases in mesothelial cells cellular differentiation influences expression. J Clin Invest. 1993;91:1792–1799.
- Martin J, Yung S, Robson RL, Production and regulation of matrix metalloproteinases and their inhibitors by human peritoneal mesothelial cells. Peri Dial Int. 2000; 20:524–533.
- Basset P, Okada A, Chenard M.-P, Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutical implications. Matrix Biol. 1997;15:535–541.
- Murphy, G, Knauper, V. Relating matrix metalloproteinase structure to function: why the ‘hemopexin’ domain? Matrix Biol. 1997;15:511–518.
- Zuhlke HV, Lorenz EM, Straub EM, Pathophysiology and classification of adhesions. Langenbecks Arch Chir Suppl II 1990;1009–1016.
- Folley-Corner AJ, Herrick SE, Al-Mishlab T, Evidence for incorporation of free-floating mesothelial cells as a mechanism of serosal healing. J Cell Sci. 2002;115:1383–1389.
- Bittinger F, Schepp C, Brochhausen C, Remodelling of peritoneal–like structures by mesothelial cells: its role in peritoneal healing. J Surg Res. 1999;82:28–33.
- Hermanowicz A, Debek W, Oksiuta M, Peritoneal cell response during adhesion formation. J Invest Surg. 2010;23(5):267–272.
- Greenawalt KE, Colt MJ, Corazzini RL, et al. Remote efficacy for two different forms of hyaluronate –based adhesion barriers. J Invest Surg. 2012;25(3):174–180.
- Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases J Pathol. 2003;200:448–464.
- Klein SA, Anderson GL, Kennedy AB, The effects of a broad-spectrum matrixmetalloproteinase inhibitor on characteristics of wound healing. J Invest Surg. 2002;15(4):199–207.
- Martin J, Yung S, Robson RL, Production and regulation of matrix metalloproteinases and their inhibitors by human peritoneal mesothelial cells. Peri Dial Int. 2000;20:524–533.
- Chegini N, Kotseos K, Zhao Y, Expression of matrix metalloproteinases and tissue inhibitor of MMP in serosal tissue of intraperitoneal organs and adhesions. Fertil Steril. 2001;76:1214–1221.
- Carolien AM, Koks MD, Groothuis PG, Matrix metalloproteinases and their tissue inhibitors in antegradely hed menstruum and peritoneal fluid. Fertil Steril. 2000; 73:604–612.
- Cheong YC, Shelton JB, Laird SM, Peritoneal fluid concentrations of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and transforming growth factor-beta in women with pelvic adhesions. Fertil Steril. 2003;79:1168–1175.
- Mirastscijski U, Johannesson K, Jeppsson B, Effect of matrix metalloproteinase activity and TNF-alpha converting enzyme inhibitor on intra-abdominal adhesions. Eur Surg Res. 2005;37:68–75.
- Diamond MP, El-Hammady E, Wang R, Regulation of matrix metalloproteinase-1 and tissue inhibitor of matrix metalloproteinase-1 by Dichloroacetic acid in human fibroblasts from normal peritoneum and adhesions. Fertil Steril. 2003;81:185–190.
- Agren MS, Jorgensen LN, Andersen M, Matrix metalloproteinase 9 level predicts optimal collagen deposition during early wound repair in humans. Br J Surg. 1998;85:715–717.
- Westermarck J, Kahari V-M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 1999;13:781–792.
- Cheong YC, Laird SM, Shelton JB, The concentration of IL-1,IL-6 and TNF-alpha in the peritoneal fluid of women with pelvic adhesions. Hum Reprod. 2001;17:69–75.